These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 7657846

  • 1. Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study.
    Babuty D, D'Hautefeuille B, Scheck F, Mycinsky C, Pruvost P, Peraudeau P.
    J Clin Pharmacol; 1995 May; 35(5):471-7. PubMed ID: 7657846
    [Abstract] [Full Text] [Related]

  • 2. [Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias].
    Maison-Blanche P, Brembilla-Perrot B, Fauchier JP, Babuty D, Garnier LF, Rouesnel P, Breuillac JC, Funck F, Scheck F, Peraudeau P, Medvedowsky JL.
    Ann Cardiol Angeiol (Paris); 1997 Feb; 46(2):109-16. PubMed ID: 9137677
    [Abstract] [Full Text] [Related]

  • 3. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [Abstract] [Full Text] [Related]

  • 4. Randomized comparison of flecainide and cibenzoline in the conversion of atrial fibrillation.
    Kühlkamp V, Schmid F, Risler T, Seipel L.
    Int J Cardiol; 1991 Apr; 31(1):65-9. PubMed ID: 1906432
    [Abstract] [Full Text] [Related]

  • 5. [Value of cibenzoline in the preventive treatment of recurrent atrial arrhythmia].
    Pisapia A, Bine-Scheck F, Schenowitz A, Domerego JJ, Maraud L, Canler A, Labban N, Viart R, Aubry P, Beruben E.
    Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):143-51. PubMed ID: 7912916
    [Abstract] [Full Text] [Related]

  • 6. [Long-term prevention of the recurrence of auricular fibrillation using cibenzoline. Multicenter study apropos of 89 case reports].
    Frances Y, Luccioni R, Delaage M, Donnarel G, Medvedowsky JL, Quiret JC.
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():99-103. PubMed ID: 3938266
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Comparative study of cibenzoline and flecainide administered via an intravenous route in reducing auricular arrhythmia].
    Metz D, Chapoutot L, Laudinat JM, Ehrhard V, Taupin JM, Chabert JP, Metivet F, Pollet E, Bajolet A.
    Ann Cardiol Angeiol (Paris); 1990 Jan; 39(1):1-6. PubMed ID: 2107784
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG.
    Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395
    [Abstract] [Full Text] [Related]

  • 14. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P, Frank R, Fontaine G, Tonet J, Tageddine R, Benassar A, Turlure A, Jacquemin M, Laborde JP.
    Arch Mal Coeur Vaiss; 1995 Dec 25; 88(12):1869-74. PubMed ID: 8729368
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients.
    Clementy J, Dulhoste MN, Laiter C, Denjoy I, Dos Santos P.
    Am J Cardiol; 1992 Aug 20; 70(5):44A-49A. PubMed ID: 1509998
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.
    Naccarelli GV, Dorian P, Hohnloser SH, Coumel P.
    Am J Cardiol; 1996 Jan 25; 77(3):53A-59A. PubMed ID: 8607392
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.